Skip to main content
Log in

Progesterone induces glioblastoma cell apoptosis by coactivating extrinsic and intrinsic apoptotic pathways

  • Original Article
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Background

Glioblastoma is a common and lethal primary brain tumor with a mean survival time less than 2 years. Progesterone, a natural steroid hormone, is a small molecule with distinct effects on glioblastoma cells. High concentrations of progesterone more than 10 µM have anti-tumor effects, but the exact mechanism remains unclear.

Objectives

Here, we continually investigate the toxic effects of high-dose progesterone on glioblastoma cells and provide a rationale for using progesterone as a therapeutic drug for glioblastoma treatment.

Results

We observed that high-dose progesterone had consistent inhibitory effect on eight different glioblastoma cell lines. Then, LN-18 and U-87 MG cells were selected for further investigations. Our results demonstrated that high concentrations of progesterone at 25, 50, and 100 µM could trigger extrinsic pathways of apoptosis by upregulating the Fas and Fas ligand. In addition, progesterone in high doses at 25, 50, and 100 µM activated the intrinsic apoptotic pathway by inhibiting anti-apoptotic proteins Bcl-2 and Bcl-xL, and promoting pro-apoptotic proteins Bax and Bak.

Conclusion

These findings suggested that both extrinsic and intrinsic apoptotic pathways contribute to glioblastoma cell apoptosis induced by high concentration of progesterone in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and material

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

Not applicable.

References

Download references

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (81673689, 81903652 and 82274120), Medical Scientific Research Foundation of Guangdong Province of China (A2022446), Excellent Young Talent Program of GDPH (KY012021187), Scientific Research Funds for High-Level Full-time Talents Introduced by GDPH (KY012021198), and Talent Project established by Chinese Pharmaceutical Association Hospital Pharmacy department (CPA-Z05-ZC-2021-003).

Author information

Authors and Affiliations

Authors

Contributions

All the authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Xiao Xiao, Yasi Zhou, Chuyin Peng and Fan Ouyang. The original draft of the manuscript was written by Yasi Zhou and Deli Song. Laiyou Wang contributed to the design of the study, providing critical comments and the editing and correction of the manuscript.

Corresponding author

Correspondence to Laiyou Wang.

Ethics declarations

Conflict of interest

The author Yasi Zhou declares that she has no conflict of interest. The author Xiao Xiao declares that she has no conflict of interest. The author Chuyin Peng declares that she has no conflict of interest. The author Deli Song declares that he has no conflict of interest. The author Fan Ouyang declares that he has no conflict of interest. The author Laiyou Wang declares that he has no conflict of interest.

Ethics approval

This article does not contain any research with human subjects or animals performed by any of the authors.

Consent to participate

All the authors have materially participated in the research and manuscript preparation.

Consent for publication

Consent for publication submission is approved by all the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

13273_2022_327_MOESM1_ESM.tif

Supplementary file1 (TIF 7046 KB) Supplementary Figure 1.Images of tumor cell after 48 hours treatment with vehicle, progesterone (50 µM) or hydrogen peroxide (1mM) respectively by transmission electron microscopy. Scale bar, 1 μm.

13273_2022_327_MOESM2_ESM.tif

Supplementary file2 (TIF 15744 KB) Supplementary Figure 2. The expression of caspases and its cleaved ones were performed by Western blot in LN-18 and U-87 MG cells after 48 h of incubation with progesterone at different concentrations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y., Xiao, X., Peng, C. et al. Progesterone induces glioblastoma cell apoptosis by coactivating extrinsic and intrinsic apoptotic pathways. Mol. Cell. Toxicol. 20, 107–117 (2024). https://doi.org/10.1007/s13273-022-00327-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13273-022-00327-w

Keywords

Navigation